Isomorphic Labs

Isomorphic Labs Raises $2.1 B to Expand AI-Driven Drug Discovery Platform

Alphabet's Isomorphic Labs Raises $2.1 Billion to Scale AI Drug Discovery Toward Clinical Trials

AstraZeneca Leads Big Pharma’s AI Clinical Trials Revolution with Real-World Patient Impact

Google's AI Drug Discovery Spinoff Isomorphic Labs Claims Major Leap Beyond AlphaFold 3

Makary Resigns, BMS Bets $15B on China R&D, and Regenxbio Wins Phase 3 in Duchenne – This Week in Biotech #100

Novartis CEO Joins Board of "Responsible" AI Firm Anthropic

The Company that Built TikTok’s Algorithm Is Now Designing Drugs for Diseases Pharma Called Undruggable

Google I/O Showed How the Path for AI-Driven Science Is Shifting

Isomorphic Labs Pulls $2.1B Series B Led By Thrive With MGX, Temasek, And UK Sovereign AI Fund: What The Capital Stack, IsoDDE Engine, And Novartis/Lilly/J&J Partnerships Mean For Drug Discovery

The Stanford Professor Behind an FDA-Cleared Cardiac AI Wants $1 Billion for His Next Company

James Wise on Why the Sovereign AI Unit Criticism Is Wrong – and the One Company He Wishes He’d Backed

ByteDance’s Anew Labs Unveils First AI‑Designed Small‑Molecule Immunotherapy

J&J Bets on Isomorphic for AI-Powered Drug Hunt

Isomorphic Labs Raises $2.1 B Series B to Scale AI Drug‑Design Engine

Isomorphic Labs Secures $2.1 B Series B to Accelerate AI Drug Discovery

New Protein-Folding AI Vastly Expands on Alphafold's Efforts

Follow the Money: AI Drug Design Engine, Treating Multiple Myeloma, Quantum Healthcare Platform

Isomorphic Labs Nears $2 Billion Funding Round Led by Thrive Capital

Google DeepMind and Edison Are Building the AI Scientist

This Week in European MedTech and HealthTech: 2nd April 2026

Researchers Warn US Politics Is Repeating Its ChatGPT Mistake with World Models

Lilly, BMS, Incyte Strike Deals to Keep Biopharma’s AI Integration Rolling

Google Talks ‘Singularity’ While Scaling up Agentic AI for Enterprises

Isomorphic Labs Pulls $2.1B Series B Led By Thrive With MGX, Temasek, And UK Sovereign AI Fund: What The Capital Stack, IsoDDE Engine, And Novartis/Lilly/J&J Partnerships Mean For Drug Discovery

Pharma Bets Big on AI Platforms with Flurry of New Year Deals

Isomorphic Raises $2.1bn for AI Drug Hunt

J&J, Isomorphic Sign Research Deal for AI-Made Molecules

Isomorphic Claims Major Advance with New AI Drug Design Engine

DeepMind Spinout Isomorphic Labs Raises $2.1bn

Takeda, Iambic Partner in Latest Pharma AI Push

Isomorphic Labs Secures $2.1 B Series B to Scale AI Drug Design Engine

Inside Incyte’s $120 Million AI For Drug Development Deal

AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials

The Operator Led Evolution in European Healthcare M&A: The Rise of Founder Bankers in HealthTech, MedTech, FemTech and Healthcare AI

Five Burning Qs for Isomorphic Labs After $2.1B Raise for AI Biotech

Isomorphic Labs Announces $600M Raise

Isomorphic Labs Closes $2.1B Series B Funding Round